Mesenteric ischemia remains a diagnostic challenge due to nonspecific symptoms, and delays in recognition lead to high ...

Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.

Liz Healy had a skiing accident so doctors ordered scans. Results showed cancer. She has fought the disease and is about to ...

“ur finding enables the safe discontinuation of follow-up after 6 years, leading to an improvement in quality of life and a reduction in health care system costs,” study researchers wrote.

The findings "suggest that endoscopic gastroenterostomy should be the palliative treatment of choice in patients with ...

Transgender surgery on minors is facing increasing pushback from medical professionals and state-level efforts to silence counselors, and may eventually be viewed with the same horror as ...

Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In ...

Shattuck Labs, Inc. ( NASDAQ: STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT ...

Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to ...

An important new study in the Journal of Hepatology, published by Elsevier, reports the world's first auxiliary liver ...

4,752,512 reviews on ConsumerAffairs are verified. We require contact information to ensure our reviewers are real. We use intelligent software that helps us maintain the integrity of reviews. Our ...